p53 and treatment of bladder cancer [2]

Nature

Volumn 385, Issue 6612, 1997, Pages 123-125

  Cote, R J ^a   Esrig, D ^a   Groshen, S ^a   Jones, P A ^a   Skinner, D G ^a   Lowe, S W ^a   Jacks, T ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; PROTEIN P53;

APOPTOSIS; BLADDER CARCINOMA; CANCER RECURRENCE; CANCER RESISTANCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; DNA DAMAGE; GENE MUTATION; HUMAN; HUMAN TISSUE; LETTER; MAJOR CLINICAL STUDY; METASTASIS; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TRANSITIONAL CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0031012872     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/385123b0     Document Type: Letter

References (18)